Senior insider sale
Chief Financial Officer at LIFECORE BIOMEDICAL, INC. \DE\ — senior position signals high conviction
$593.3K
102.60K shares
What this filing means
MORBERG JOHN D plans to sell 102.60K shares of LIFECORE BIOMEDICAL, INC. \DE\ valued at approximately $593.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/12/2024ACC: 0001957799-24-000319
Officer· Chief Financial Officer
Since Jan 2021
102.60K
Shares to sell
$593.3K
Approx. market value
81.98K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months2
Bonus
N/A
10/6/2024
4KRSUs
N/A
9/26/2024
77.98KTotal acquired81.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/6/2024 | Bonus N/A | 4K | — |
9/26/2024 | RSUs N/A | 77.98K | — |
| Total | 81.98K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
40.99K
Market value
$232.9K
10/31/2024
—Completed
Units to sell
5.19K
Market value
$25.6K
10/17/2024
—Completed
Units to sell
7.43K
Market value
$38.0K
10/7/2024
—Completed
Units to sell
12K
Market value
$60.7K
10/4/2024
—Completed
Units to sell
3K
Market value
$14.7K
10/2/2024
—Completed
Units to sell
3K
Market value
$15.5K
9/20/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
30.99K
Market value
$205.8K
11/11/2024
Total
Units
102.60K
Value
$593.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/31/2024 | 40.99K | $232.9K | — | Completed |
10/17/2024 | 5.19K | $25.6K | — | Completed |
10/7/2024 | 7.43K | $38.0K | — | Completed |
10/4/2024 | 12K | $60.7K | — | Completed |
10/2/2024 | 3K | $14.7K | — | Completed |
9/20/2024 | 3K | $15.5K | — | Completed |
| Planned — Approximate Date | ||||
11/11/2024 | 30.99K | $205.8K | Nasdaq | Planned |
| Total | 102.60K | $593.3K | ||